Author:
Fávaro W.J.,Alonso J.C.C.,de Souza B.R.,Reis I.B.,Gonçalves J.M.,Deckmann A.C.,Oliveira G.,Dias Q.C.,Durán N.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado de São Paulo
Subject
Cell Biology,Developmental Biology,General Medicine
Reference55 articles.
1. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors;Alshaker;Cancer Cell Int,2011
2. Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer: Results from phase I/ II study;Alonso;J. Clin. Oncol.,2020
3. Safety and efficacy of oncotherad nano-immunotherapy in patients with non-muscle invasive bladder cancer;Alonso;J. Phys. Conf. Ser.,2021
4. Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG);Balar;J. Clin. Oncol.,2019
5. Intravesical Bacillus Calmette-Guérin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity;Böhle;J. Urol.,2003
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献